One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
ROI, COI, and the Ethical Obligations of Journals
Russell N.Van GelderMD, PhDCarla J.SiegfriedMD
Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study
Michael A.SingerMD1VeeralShethMD, MBA2Sam E.MansourMD, MSc34BrandonCoughlinPhD5Victor H.GonzalezMD6
Results of the United States Food and Drug Administration Clinical Trial of the CustomFlex Artificial Iris
Brandon D.AyresMD1Barbara S.FantPharmD2Zachary C.LandisMD3Kevin M.MillerMD4R. DoyleStultingMD, PhD5Robert J.CionniMD6Nicole R.FramMD7StephenHamiltonMD8David R.HardtenMD9Douglas D.KochMD10SamuelMasketMD47Francis W.PriceJr.MD11Kenneth J.RosenthalMD12M. BowesHamillMD10Michael E.SnyderMD1314
Corneal Keloid in Lowe Syndrome
Gilles C.MartinMD, MScMarcPuttermanMDPascalDureauMD, PhD
Genome-Wide Association Study Identifies Two Common Loci Associated with Pigment Dispersion Syndrome/Pigmentary Glaucoma and Implicates Myopia in its Development
Mark J.SimcoePhD123AmeetShahMD(Res), FRCOphth4BaojianFanMD, PhD5HélèneChoquetPhD6NicoleWeisschuhPhD7Naushin H.WaseemPhD3ChenJiangPhD6Ronald B.MellesMD8RobertRitchMD, FRCOphth9Omar A.MahrooPhD, FRCOphth123BerndWissingerPhD7EricJorgensonPhD6Janey L.WiggsMD, PhD5David F.Garway-HeathMD, FRCOphth10Pirro G.HysiPhD12Christopher J.HammondMD, FRCOphth12
Alcohol, Intraocular Pressure, and Open-Angle Glaucoma: A Systematic Review and Meta-analysis
Kelsey V.StuartMBBCh, MSc1KianMadjediMD, MPhil2Robert N.LubenPhD3Sharon Y.L.ChuaPhD1Alasdair N.WarwickMBBS, BSc4MarkChiaMBBS(Hons), MMed1Louis R.PasqualeMD5Janey L.WiggsMD, PhD6Jae H.KangScD7Pirro G.HysiPhD89Jessica H.TranBS5Paul J.FosterPhD, FRCS(Ed)1‡Anthony P.KhawajaPhD, FRCOphth1‡Modifiable Risk Factors for Glaucoma Collaboration∗
Functional Amblyopia in Segmental Optic Nerve Hypoplasia
Blake H.FortesMDMichael C.BrodskyMD
Cuticular Drusen in Age-Related Macular Degeneration: Association with Progression and Impact on Visual Sensitivity
Kai LynGohBOptom12Fred K.ChenMBBS, PhD34ChandrakumarBalaratnasingamMBBS, PhD35Carla J.AbbottBOptom, PhD12Lauren A.B.HodgsonMPH1Robyn H.GuymerMBBS, PhD12ZhichaoWuBAppSc(Optom), PhD12
Spontaneous Regression of Presumed Iris Melanocytoma
Corrina P.AzarconMDJill R.WellsMD
Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial
EdmundTsuiMD123Sivakumar R.RathinamMD, PhD4John A.GonzalesMD12RadhikaThundikandyMD4AnuradhaKanakathMD5S.BalamuruganMD6R.VedhanayakiMD4Lyndell L.LimMBBS, DMedSci7Eric B.SuhlerMD, MPH8Hassan A.Al-DhibiMD9ThuyDoanMD, PhD12JeremyKeenanMD12Caleb D.EbertMPH1EricKimMA1BrianMadowMD10Travis C.PorcoPhD1211Nisha R.AcharyaMD, MS1211FAST Research Group∗
An Unusual Cause of Choroidal Excavation
Shaymaa H.SalahMD, PhD1Mohamed A.ElsherifMD, PhD2Ayman G.ElnahryMD, PhD1
Visual Field Loss Impacts Vision-Specific Quality of Life by Race and Ethnicity: The Multiethnic Ophthalmology Cohorts of California Study
Dominic J.GrisafeIIPhD1RobertaMcKean-CowdinPhD, MPH1Bruce S.BurkemperPhD, MPH1Benjamin Y.XuMD, PhD2MinaTorresMS3RohitVarmaMD, MPH3
Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients
Sara E.LallyMD1TatyanaMilmanMD2MarlanaOrloffMD3Lauren A.DalvinMD8Charles G.EberhartMD, PhD45Christopher M.HeaphyPhD46Fausto J.RodriguezMD4Chun-ChiehLinMD, PhD47Philip W.DockeryMD, MPH1Jerry A.ShieldsMD1Carol L.ShieldsMD1
Photoreceptor Layer Thinning Is an Early Biomarker for Age-Related Macular Degeneration: Epidemiologic and Genetic Evidence from UK Biobank OCT Data
Seyedeh MaryamZekavatBS1234SayuriSekimitsuBS5YixuanYeBS2VineetRaghuPhD346HongyuZhaoPhD27TobiasElzePhD8Ayellet V.SegrèPhD8Janey L.WiggsMD, PhD8PradeepNatarajanMD, MSSc34∗LucianDel PrioreMD, PhD1∗NazleeZebardastMD8∗Jay C.WangMD19∗
Genotypic and Phenotypic Spectrum of Foveal Hypoplasia: A Multicenter Study
Helen J.KuhtBMedSci, PhD128Gail D.E.MaconachieBMedSci, PhD1228JinuHanMD328LineKesselMD, PhD4528Maria M.van GenderenMD, PhD6728Rebecca J.McLeanMSc, PhD1MichaelHisaundBMedSci1ZhanhanTuMBChB, PhD128Richard W.HertleMD828KarenGronskovPhD928DayongBaiMD, PhD1028AihuaWeiMD, PhD1128WeiLiPhD1228YonghongJiaoMD1328VasilySmirnovMD1428Jae-HwanChoiMD1528Martin D.TobinMD1628ViralShethBMedSci, PhD12…Mervyn G.ThomasPhD, FRCOphth128
Ultrawide-field OCT for Retinoblastoma
Alison H.SkaletMD, PhD1234J. PeterCampbellMD, MPH1YifanJianPhD15
The Pandemic Is Not Associated with Endophthalmitis Decrease after Anti–Vascular Endothelial Growth Factor Injections
FloraLumMD1SiyingLiMS1LynnLiuMS1CharlesLiBA1David W.ParkeIIMD1George A.WilliamsMD2
Time to Uveitis Control with Methotrexate and Mycophenolate Mofetil
Anh D.BuiMD, PhD1Christina L.KongMD2Nicole K.KellyMPH2S.R.RathinamMD, PhD3John A.GonzalesMD12RadhikaThundikandyMD3AnuradhaKanakathMD4BalaMuruganMD5R.VedhanayakiMD3Lyndell L.LimMBBS, DMedSci6Eric B.SuhlerMD, MPH7Hassan A.Al-DhibiMD8ThuyDoanMD, PhD12Nisha R.AcharyaMD, MS129First-Line Antimetabolites as Steroid-Sparing Treatment Research Group∗
Re: Chiang et al.: International Classification of Retinopathy of Prematurity: Third Edition (Ophthalmology. 2021;128:e51–e68)
KomalAgarwalFRCS1SushmaJayannaDNB2Tapas RanjanPadhiMS3SameeraNayakMS4SubhadraJalaliMS1
Reply
Graham E.QuinnMD, MSCE1Alastair R.FielderFRCP2R.V. PaulChanMD3Michael F.ChiangMD4International Committee for the Classification of Retinopathy of Prematurity
Re: Le et al.: Associations between age-related eye diseases and Charles Bonnet Syndrome in participants of the Age-Related Eye Disease Study 2: Report Number 26 (Ophthalmology. 2022;129:233–235)
Gary C.BrownMD, MBA1234Robert P.MurphyMD5
Reply
Jimmy T.LeScD, MA1DavidPeprahMA2ElviraAgrónMA1Tiarnan D.L.KeenanBM BCh, PhD1Traci E.ClemonsPhD3Emily Y.ChewMD1
